Category Archives: Mesenchymal Stem Cells

Regenocyte Adult Stem Cell Therapy -Howard Lindeman By: RegenocyteStemCells … Continue reading →

Regenocyte Adult Stem Cell Therapy - Barbara McKean By: RegenocyteStemCells … Continue reading →

stem cell therapy treatment for beckers muscular dystrophy by dr alok sharma, mumbai, india [gujarati] improvement seen in just 5 days after stem cell therapy treatment for beckers muscular dystrophy by dr alok sharma, mumbai, india. Stem Cell Thera... By: Neurogen Brain and Spine Institute … Continue reading →

Primary Outcome Measures: Secondary Outcome Measures: Treatment of nonunion, delayed union and malunion fractures of long bones remains problematic. The definition of nonunion is a failure of the fracture to heal in six months in a patient in whom progressive repair had not been observed radiographically between the third and sixth month after the fracture. Nonunion is a serious complication of a fracture, occurring in 2-10% of patients, as it is associated with high economic and health burden. Many cases are subsequently approached by multiple surgical and nonsurgical modalities. Various devices, under the name of "bone growth stimulators" have been used to enhance healing of the fracture. Recent studies, demonstrated the efficacy of mesenchymal stem cells in regeneration of bone and cartilage tissue. In this study percutaneous injection of mesenchymal stem cells to the site of fracture is performed as an outpatient procedure or during an operative exposure to evaluate its efficacy in enhancing bone regeneration. In the case of small size of bone gap, mesenchymal stem cells are injected into the callus of fracture site through an outpatient procedure under the guide of fluoroscopy. If there is a large bone gap, through a surgical management, mesenchymal stem cells seeded … Continue reading →

Dr. Aidan R. Raney performs a checkup on heart attack patient Mark Athens, 52, on Tuesday, Dec. 17, at Scripps Green Hospital in La Jolla. Athens received a stem cell treatment to help his heart recover as part of a clinical trial to determine the treatments safety and effectiveness. A new stem cell treatment may help heart attack patients do something once thought medically impossible regenerate dead heart muscle. Scripps Health in La Jolla is one of three centers testing the therapy from Capricor, a Los Angeles biotech company. The cardiac stem cells are meant to boost the hearts natural ability to perform minor repairs. If it works, scars should shrink and functional heart muscle should grow. Capricor gets the cells from donor hearts, grows them into the amount needed for treatment, then sends them to doctors taking part in what is called the Allstar trial. Doctors inject the cells into the coronary artery, where they are expected to migrate to the heart and encourage muscle regrowth. The trial has successfully completed Phase 1, which mainly evaluates safety. On Dec. 17, Capricor said it had received permission to begin Phase 2, which will examine efficacy in about 300 patients who … Continue reading →

PUBLIC RELEASE DATE: 26-Dec-2013 Contact: Mary Beth O'Leary moleary@cell.com 617-397-2802 Cell Press Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ISSCR's journal Stem Cell Reports, published by Cell Press, researchers evaluated a patient with a genetic skin disorder known as epidermolysis bullosa (EB) nearly seven years after he had undergone a gene therapy procedure as part of a clinical trial. The study revealed that a small number of skin stem cells transplanted into the patient's legs were sufficient to restore normal skin function, without causing any adverse side effects. "These findings pave the way for the future safe use of epidermal stem cells for combined cell and gene therapy of epidermolysis bullosa and other genetic skin diseases," says senior study author Michele De Luca of the University of Modena and Reggio Emilia. EB is a painful condition that causes the skin to be very fragile and to blister easily, and it can also cause life-threatening infections. Because there is no cure for the disease, current treatment strategies focus on relieving symptoms. To evaluate stem cell-based … Continue reading →

Some of the promise of stem cell therapy has been realized. A prime example is bone marrow transplantation. Even here, however, manyproblems remain to be solved. Challenges facing stem cell therapy include the following: Adult stem cells Tissue-specific stem cells in adult individuals tend to be rare. Furthermore, while they can regenerate themselves in an animal or person they are generally very difficult to grow and to expand in the laboratory. Because of this, it is difficult to obtain sufficient numbers of many adult stem cell types for study and clinical use. Hematopoietic or blood-forming stem cells in the bone marrow, for example, only make up one in a hundred thousand cells of the bone marrow. They can be isolated, but can only be expanded a very limited amount in the laboratory. Fortunately, large numbers of whole bone marrow cells can be isolated and administered for the treatment for a variety of diseases of the blood. Skin stem cells can be expanded however, and are used to treat burns. For other types of stem cells, such as mesenchymal stem cells, some success has been achieved in expanding the cellsin vitro, but application in animals has been difficult. One major problem … Continue reading →

Mesenchymal stem cells (MSCs) are pluripotent cells found in multiple human adult tissues including bone marrow, synovial tissues, and adipose tissues. Since they are derived from the mesoderm, they have been shown to differentiate into bone, cartilage, muscle, and adipose tissue.[1] MSCs from embryonic sources have shown promise scientifically while creating significant controversy. As a result, many researchers have focused on adult stem cells [1], or stem cells isolated from adult humans that can be transplanted into damaged tissue. Because of their multi-potent capabilities, mesenchymal stem cell (MSC) lineages have been used successfully in animal models to regenerate articular cartilage and in human models to regenerate bone.[2][3][4] Recent research demonstrates that articular cartilage may be able to be repaired via percutaneous introduction of mesenchymal stem cells (MSCs).[5] Research into MSCs has exploded in recent years. As an example, a PubMed search for the year 1999 reveals about 90 papers published under the MESH heading of Mesenchymal Stem Cells, the same search ran for the year 2007 reveals more than 4,000 entries. The most commonly used source of MSCs is bone marrow aspirate. Most of the adult bone marrow consists of blood cells in various stages of differentiation.[6] These marrow components … Continue reading →

Stem cell therapy in India for Avascular Necrosis By: StemRx BioScience … Continue reading →

Orange County, California (PRWEB) December 23, 2013 The top stem cell therapy clinic in California, TeleHealth, is now offering PRP therapy for hip arthritis. The treatments are often able to delay or avoid the need for joint replacement, and are administered by Board Certified doctors at two clinic locations. Call (888) 828-4575 for more information and scheduling. Tens of millions of Americans suffer from hip arthritis, and hundreds of thousands of hip replacements are performed every year. Nonoperative treatments prior to joint replacement often consist of steroid injections for pain relief. While the joint replacement typically has excellent pain relief outcomes, there are risks involved and sometimes the eventual need for a revision procedure. Therefore, a procedure that offers pain relief while offering the potential for joint repair is a welcome option in hip arthritis management. TeleHealth is now offering platelet rich plasma therapy, known as PRP therapy for short, to provide pain relief and potential joint regeneration. The procedure involves a simple blood draw at the office, with the blood then being spun down in a centrifuge to obtain a solution of concentrated platelets and growth factors. The PRP is then injected into the symptomatic hip, providing an immense … Continue reading →